Rowan Walrath
@rowanwalrath
Followers
2K
Following
44K
Media
746
Statuses
8K
Associate editor, life sciences reporter @cenmag. Texan Bostonian. she/her. [email protected]. Encrypted comms: Signal @rowanwalrath.01, [email protected]
Boston, MA
Joined May 2012
Academic researchers want to repurpose drugs for #LongCOVID. Manufacturers aren’t supplying them. 🧵
1
71
245
Moderna says key study of its CMV vaccine, expected to be its next big win, failed w/@Jasonmmast
https://t.co/14YuBm2Bwo via @statnews
statnews.com
Moderna said its experimental vaccine for cytomegalovirus failed in a key trial, a significant setback for a company already facing pressure from Wall Street and Washington.
0
4
11
RMC-6236 (daraxonrasib) - pancreatic cancer - Revolution Medicines
1
0
0
Ketamine - anesthesia, "the priority is domestic manufacturing" - Flow Augmentin - antibiotic, domestic manufacturing - sponsor?? Pergoveris - infertility - Merck KGaA Bitopertin - erythropoietic protoporphyria - Disc Medicine ...
1
0
0
Cytisine - vaping cessation - Achieve Life Sciences Cenegermin-BKBJ intranasal - vision restoration in non-arteritic anterior ischemic optic neuropathy - Dompé Farmaceutici Teplizumab - Type 1 diabetes - Sanofi DB-OTO - genetic deafness - Regeneron ...
FDA will be proactive in advancing decisions on medicines serving a key national priority: affordability, domestic production, or meeting an unmet public health need.
1
0
1
Have you been wondering how the FDA came to ask $GSK to file to have leucovorin approved for some types of autism? The details of that decision -- the director of the FDA's drug division negotiated a tense bargan with agency staff -- are only the start of this important piece
statnews.com
Current and former FDA staff said the level of involvement of political officials in nitty-gritty regulatory matters is unprecedented.
8
34
60
Thank you @rowanwalrath for speaking with our CEO, Usman "Oz" Azam, MD, this week and highlighting our lead autoimmune candidate, CUE-401, inspired by the Nobel Prize-winning discoveries behind Peripheral Tolerance. Learn more in @cenmag’s article below.
Nobel-winning T regs have fueled a new class of immunology companies. https://t.co/bEVg8s5qLC
@cenmag
0
1
2
Nobel-winning T regs have fueled a new class of immunology companies. https://t.co/bEVg8s5qLC
@cenmag
cen.acs.org
Nobel Prize–winning technology engineered to treat autoimmune diseases and cancer
0
1
6
According to the immunologist Alice Denton, researchers have been speculating for a while that regulatory T cells might win a #NobelPrize because the findings are so important: https://t.co/7TWsGlnzAm Learn more about cell therapies for autoimmunity:
cen.acs.org
A flurry of financial activity from cell therapy companies focused on regulatory T cells
1
2
5
I wrote about Invivyd's strategy here last month in @cenmag
cen.acs.org
Invivyd is developing drugs meant to stave off the worst outcomes of the virus
0
0
0
Invivyd is launching a trial that will pit its COVID-prevention antibody head to head against mRNA vaccines
investors.adagiotx.com
The DECLARATION (safety and efficacy vs. placebo) and LIBERTY (exploratory safety head-to-head and combination with mRNA-based COVID vaccination) clinical trials are expected to begin around year-end...
1
0
0
Immunity researchers win the 2025 #NobelPrize in Physiology or Medicine Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi receive the prize for understanding how the immune system is kept in check. Read more: https://t.co/7TWsGln1KO
0
5
12
The gov't shutdown means FDA is not accepting drug-approval applications. I did quick scan of potentially affected drug makers, defined by me as companies that have guided to filings by EOY. $VRDN $RNA $MRNA $COGT $VERA Any others, add in replies.
25
11
86
😀Our podcast Inflection Point has been nominated for not one but two #SignalAwards! You can vote for us under the categories: 👉 Best Co-Host Team: https://t.co/n45YbOeYcZ and 👉 Science and Education: https://t.co/m8u1wvG8FD
1
1
5
It gets earlier every year... Next Wednesday, join me and an expert panel to discuss who might win the 2025 #ChemNobel. Free to attend. Date: Wednesday, October 1, 2025 Time: 2–3 PM ET Register here: https://t.co/kRAddjBXS2
0
6
6
FDA's move to update old GSK drug for autism raises questions on dose, supply and data -
endpoints.news
The FDA is calling on GSK to update the label for a now-generic drug called leucovorin that it stopped selling more than 28 years ago, claiming an agency review of the medical literature shows it...
2
2
6
We are less than one hour out from the scheduled time that the committee will vote on new Covid-19 vaccine recommendations. The voting language has not been made public.
2
1
8
Artur Mylin lost half a leg fighting in Ukraine. A year later, he walked back into the lab to defend his country in a new way. @rowanwalrath wrote a knockout about him:
cen.acs.org
This physical chemist shifted from catalysis to combat to defense research
1
1
0
As we went through about 100 nominations, recruited a bunch of science writers with disabilities, and started building these profiles, i realized that i knew kind of a lot.
1
1
0